Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Smith & Nephew Plc LSE:SN. London Ordinary Share GB0009223206 ORD USD0.20
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -3.00 -0.2% 1,517.00 1,509.50 1,510.50 1,530.00 1,500.50 1,508.00 1,800,857 16:35:11
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 3,874.2 560.2 51.7 27.9 13,270

Smith & Nephew Share Discussion Threads

Showing 876 to 899 of 900 messages
Chat Pages: 36  35  34  33  32  31  30  29  28  27  26  25  Older
DateSubjectAuthorDiscuss
10/5/2020
09:36
MIDAS SHARE TIPS: Hip replacement company Smith & Nephew can ease the pain of lockdown for investors https://www.dailymail.co.uk/money/investing/article-8303561/MIDAS-SHARE-TIPS-Smith-Nephew-ease-pain-lockdown.html
philanderer
09/5/2020
15:21
I think perhaps the intro to the thread needs updating with some more recent information. Dec 2010 seems quite a long time ago now :-) Am long SN. and have been for a few years. Wish I'd had the money to top up on the dip.
cokehookerscars
06/5/2020
12:23
don't forget they are involved with the dreaded covid in some form or other. looks as though its onwards and upwards from here.
abbynat
06/5/2020
08:23
Surprised that markets have opened up. I'm a holder, and would have topped up with an significant falls, so didnt mind either way really!
adamb1978
06/5/2020
08:00
Looks as though massive fall in elective surgery with significant hit - as expected but will have to see when market opens if already in the recovered price or will we take a retrace hit this morning?
pugugly
15/3/2020
12:22
PUG, thanks for highlighting. Back on a watchlist.
essentialinvestor
15/3/2020
12:18
Looks as though may be wors than I thought "The health service is to stop non-urgent surgery" https://www.bbc.com/news/uk-51895873 Could be good for another 10%+ fall on Monday. More possibly if margin calls -
pugugly
12/3/2020
16:17
Back into freefall - Now 1330p So guesses as to how much further to fall - Nothing company specific just I suspect COVID panic BUT with hospitals overflowing with accutely ill patients bound to be a signifcant (say 20%++ on elective surgery such as hips - So indirect COVID impact - REDUCED usage of products.
pugugly
20/2/2020
09:30
God bless Namal for the buy-back-dip :-)
knighty0001
20/2/2020
09:16
Great results who needs Namal.Or Goldman sacks
peteret
20/2/2020
08:36
Excellent figures.New all time intraday day high.
steeplejack
19/2/2020
18:59
1900 plus tomorrow. Good luck all and happy days.
knighty0001
19/2/2020
09:20
Big day tomorrow rise already starting
peteret
12/2/2020
15:03
Brenenberg broker issued a buy recommendation today and raised its target from 21.85 to 23.25.Why is it still dropping.
peteret
12/2/2020
14:54
Why is this dropping so much on no news
peteret
21/10/2019
23:51
Broker notes: "Smith&Nephew CEO steps down, surprising analysts and triggering sharp selling" HTTPS://www.sharecast.com/news/news-and-announcements/smithnephew-ceo-steps-down-surprising-analysts-and-triggering-sharp-selling--7085445.html
philanderer
21/10/2019
23:42
Berenberg keeping their rating unchanged today ... 'buy' tp 2250p ..as do Shore Cap with their 'sell'
philanderer
21/10/2019
21:50
The company is certainly strong and I think what Namal brought was some guts to go out and start buying up small med tech companies to bolster the portfolio which if definitely the right way to go. I do hope his successor continues the momentum, sales are not going to diminish due to his departure, I think it is safe to day that medical device manufacturers are a good buy, with people living longer and the demand on healthcare increasing. The majority of the share price valuation was based on Namal's attitude to business and believe it will recover in time. In my opinion, we have an excellent t buying opportunity ahead and like you said, could very well be snapped up by a bigger fish any time.
kknight01
21/10/2019
10:46
£14 ?.....The chart would suggest as much.Currency factors are now moving against overseas earners. It’s difficult.It’s one of those situations where you can understand why a stock is falling but don’t know whether to sell and buy back in lower (easier said than done) or simply buy more on the basis that the company is fundamentally sound and doing well.I’m inclined to buy more on the basis that the company is doing well and as instrumental as Namal might is/has been in the company’s success,one man is not irreplaceable.I purchased shares because of the company’s niche market position and the undoubted attractiveness of its product range not the strength of management per se.Also,as we all know,this company has been stalked by predators before and will be again.I don’t see this company being independent in three years time.
steeplejack
21/10/2019
10:36
Where the decline will stop no one knows but with a Q3 results announcement due soon, and depending how well Q3 has been, these could go back to 2018 levels of £14.
kknight01
21/10/2019
10:34
Financial times have put some detail around this....... Namal wanted to move listing from UK to US so he could boost his pay (with the company listed in the UK there are restrictions on exec salary). Guessing the board disagreed and he decided to leave. All comes down to money in the end, shame really as I know a lot of people believed in Namal to turn this great company into something greater.
kknight01
21/10/2019
09:55
Smith & Nephew"Can anything stop the exodus of FTSE 100 chief executives in 2019? The numbers have now been bolstered to the point where these departing CEOs could almost cobble together an 11-a-side football match as Smith & Nephew's Namal Nawana steps down."Australian Nawana has only been in post for 18 months but has already helped revive the share price with a new strategy."This culminated in re-organising the business into three global franchises: orthopaedics, sports medicine and advanced wound management."The market responded positively to this simplified structure, which reduced duplication of effort and made reporting responsibilities clearer with better accountability."There appears to be a pretty simple reason Nawana is leaving – pay. It became apparent over the summer that the company was looking for ways to increase its head honcho's remuneration with apparent discussions about a move to a US listing to escape an increasing backlash in the UK towards excessive executive pay."The fear will be that this revamp of the business will be derailed by Nawana's departure despite efforts to allay these concerns – with internal candidate Roland Diggelmann stepping up to the top job and Nawana staying to smooth the transition until the end of the year."Diggelmann faces a tricky task of balancing the need for continuity with a likely ambition to bring his own ideas to the role."
steeplejack
21/10/2019
09:04
Market doesn’t like the fact that Namal Nawana is stepping down and probably doesn’t appreciate the lack of detail accompanying that announcement.Then they’re appointing a non executive as a replacement which strikes one as unusual.
steeplejack
21/10/2019
08:58
CEO change.
steeplejack
Chat Pages: 36  35  34  33  32  31  30  29  28  27  26  25  Older
ADVFN Advertorial
Your Recent History
LSE
SN.
Smith & Ne..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200712 00:46:46